Michikazu Abe

Title: Michikazu Abe: Innovator in Circadian Rhythm Research

Introduction

Michikazu Abe is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of genetic engineering, particularly in the study of circadian rhythms. His innovative work has implications for understanding various diseases and disorders related to these biological cycles.

Latest Patents

Abe holds a patent for a groundbreaking invention titled "Transgenic mammals introduced a Period 1 promoter that confers rhythmical expression." This patent involves an isolated Period 1 (Per1) promoter DNA that induces rhythmical expression of a gene operably linked to it. The invention also encompasses a DNA comprising a Period 1 promoter DNA and a gene under its regulation. Furthermore, it provides transformants and transgenic mammals into which this DNA has been introduced. These transformants and transgenic mammals are valuable for screening pharmaceutical drugs aimed at treating diseases associated with circadian rhythm disruptions. He has 1 patent to his name.

Career Highlights

Throughout his career, Michikazu Abe has worked with esteemed organizations, including the University of Virginia Patent Foundation and Mitsubishi Pharma Corporation. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Abe has collaborated with notable colleagues such as Shin Yamazaki and Ri-ichi Takahashi. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Michikazu Abe's innovative work in the field of circadian rhythms and genetic engineering highlights his role as a significant inventor. His contributions continue to influence research and development in this important area of science.